News
December 7, 2021
An international team of scientists, including MSU researchers, believe they may have found a molecular mechanism behind the extremely rare blood clots linked to adenovirus COVID-19 vaccines. Their findings, which were recently published in the international journal Science Advances, suggest it is the viral vector and the way it binds to platelet factor 4 (PF4) once injected that could be the potential mechanism that triggers blood clots in a very small number of people after the vaccine is administered.